β-Adrenoceptor modulation of transiently overexpressed α 2-adrenoceptors in brain and peripheral tissues: Cellular mechanisms underlying the developmental toxicity of terbutaline

Brain Research Bulletin

Volumn 62, Issue 4, 2004, Pages 305-314

  Kreider, Marisa L ^a   Seidler, Frederic J ^a   Slotkin, Theodore A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

6 Hydroxydopamine; Brain development; Heart development; Kidney development; Liver development; Preterm labor; Sympathetic nervous system; Terbutaline; 2 Adrenoceptor; Adrenoceptor

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOSYNTHESIS; BRAIN; BRAIN REGION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NEWBORN PERIOD; NONHUMAN; PHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; TISSUE DISTRIBUTION;

EID: 0347356252     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2003.09.017     Document Type: Article

References (72)

1. Auman J.T., Seidler F.J., Slotkin T.A. Regulation of fetal cardiac and hepatic β-adrenoceptors and adenylyl cyclase signaling: terbutaline effects. Am. J. Physiol. 281:2001;R1079-R1089.
2. Auman J.T., Seidler F.J., Slotkin T.A. β-Adrenoceptor control of G-protein function in the neonate: determinant of desensitization or sensitization. Am. J. Physiol. 283:2002;R1236-R1244.
3. Auman J.T., Seidler F.J., Tate C.A., Slotkin T.A. β-Adrenoceptor- mediated cell signaling in the neonatal heart and liver: responses to terbutaline. Am. J. Physiol. 281:2001;R1895-R1901.
4. Auman J.T., Seidler F.J., Tate C.A., Slotkin T.A. Are developing β-adrenoceptors able to desensitize? Acute and chronic effects of β-agonists in neonatal heart and liver. Am. J. Physiol. 283:2002;R205-R217.
5. Azevedo I., Osswald W. Trophic role of the sympathetic innervation. J. Pharmacol. 17:1986;30-43.
6. Bartolomé J.V., Kavlock R.J., Cowdery T., Orband-Miller L., Slotkin T.A. Development of adrenergic receptor binding sites in brain regions of the neonatal rat: effects of prenatal or postnatal exposure to methylmercury. Neurotoxicology. 8:1987;1-14.
7. 1- and β-adrenoceptors and phospholipid fatty acids in rat heart. Eur. J. Pharmacol. 289:1995;419-427.
8. Bergman B. Beta-mimetics and the preterm neonatal lung. Acta Physiol. Scand. Suppl. 497:1981;1-52.
9. Bergman B., Bokström H., Borga O., Enk L., Hedner T., Wängberg B. Transfer of terbutaline across the human placenta in late pregnancy. Eur. J. Resp. Dis. 65:1984;81-86.
10. Berkowitz G.S., Papiernik E. Epidemiology of preterm birth. Epidemiol. Rev. 15:1993;414-443.
11. Bey M., Blanchard A.C., Darnell J., Stephens K. Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline for suppression of premature labor. Am. J. Obstet. Gynecol. 167:1992;292.
12. Caritis S.N., Darby M.J., Chan L. Pharmacologic treatment of preterm labor. Clin. Obstet. Gynecol. 31:1988;635-651.
13. Dreyfus C.F. Neurotransmitters and neurotrophins collaborate to influence brain development. Perspect. Dev. Neurobiol. 5:1998;389-399.
14. Duncan C.P., Seidler F.J., Lappi S.E., Slotkin T.A. Dual control of DNA synthesis by α- and β-adrenergic mechanisms in normoxic and hypoxic neonatal rat brain. Dev. Brain Res. 55:1990;29-33.
15. 2A-adrenergic receptor expression in the rat brain. Psychoneuroendocrinology. 27:2002;585-592.
16. Erdtsieck-Ernste B.H.W., Feenstra M.G.P., Boer G.J. Pre- and postnatal developmental changes of adrenoceptor subtypes in rat brain. J. Neurochem. 57:1991;897-903.
17. Ernsberger P., Feinland G., Meeley M.P., Reis D.J. Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substances. Am. J. Hypertens. 3:1990;90-97.
18. Fletcher S.E., Fyfe D.A., Case C.L., Wiles H.B., Upshur J.K., Newman R.B. Myocardial necrosis in a newborn after long-term maternal subcutaneous terbutaline infusion for suppression of preterm labor. Am. J. Obstet. Gynecol. 165:1991;1401-1404.
19. Garofolo M.C., Seidler F.J., Auman J.T., Slotkin T.A. β-Adrenergic modulation of muscarinic cholinergic receptor expression and function in the developing heart. Am. J. Physiol. 282(1404):2002;R1356-R1363.
20. Garofolo M.C., Seidler F.J., Cousins M.M., Tate C.A., Qiao D., Slotkin T.A. Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver. Brain Res. Bull. 59:2003;319-329.
21. Goldenberg R.L. The management of preterm labor. Obstet. Gynecol. 100:2002;1020-1037.
22. Habecker B.A., Malec N.M., Landis S.C. Differential regulation of adrenergic receptor development by sympathetic innervation. J. Neurosci. 16:1996;229-237.
23. Hohmann C.F., Berger-Sweeney J. Cholinergic regulation of cortical development and plasticity: new twists to an old story. Perspect. Dev. Neurobiol. 5:1998;401-425.
24. Ingemarsson I., Westgren M., Lindberg C., Ahrén B., Lundquist I., Carlsson C. Single injection of terbutaline in term labor: placental transfer and effects on maternal and fetal carbohydrate metabolism. Am. J. Obstet. Gynecol. 139:1981;697-701.
25. Kauffman K.S., Seidler F.J., Slotkin T.A. Prenatal dexamethasone exposure causes loss of neonatal hypoxia tolerance: cellular mechanisms. Pediatr. Res. 35:1994;515-522.
26. Kudlacz E.M., Navarro H.A., Eylers J.P., Dobbins S.S., Lappi S.E., Slotkin T.A. Selective linkage of β-adrenergic receptors to functional responses in developing rat lung and liver: phosphatidic acid phosphatase ornithine decarboxylase and lung liquid reabsorption. J. Dev. Physiol. 12:1989;129-134.
27. Kudlacz E.M., Navarro H.A., Slotkin T.A. Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation. J. Pharmacol. Exp. Ther. 250:1989;236-240.
28. Kudlacz E.M., Slotkin T.A. Regulation of neonatal rat lung compliance by β-adrenergic receptor stimulation: effects of prenatal exposure to terbutaline or dexamethasone. J. Dev. Physiol. 14:1990;307-310.
29. Lagercrantz H., Slotkin T.A. The "stress" of being born. Sci. Am. 254(April):1986;100-107.
30. Lam F., Elliott J., Jones J.S., Katz M., Knuppel R.A., Morrison J., Newman R., Phelan J., Willcourt R. Clinical issues surrounding the use of terbutaline sulfate for preterm labor. Obstet. Gynecol. Surv. 53:1998;S85-S95.
31. 2-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology. 96:2002;134-141.
32. J.M. Lauder, Roles for neurotransmitters in development: possible interaction with drugs during the fetal and neonatal periods, in: M. Marois (Ed.), Prevention of Physical and Mental Congenital Defects, Alan R. Liss, New York, 1985, pp. 375-380.
33. Lauder J.M., Schambra U.B. Morphogenetic roles of acetylcholine. Environ. Health Perspect. 107(Suppl. 1):1999;65-69.
34. Lenselink D.R., Kuhlmann R.S., Lawrence J.M., Kolesari G.L. Cardiovascular teratogenicity of terbutaline and ritodrine in the chick embryo. Am. J. Obstet. Gynecol. 171:1994;501-506.
35. Li F.Q., Wang X.J., Capasso J.M., Gerdes A.M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 28:1996;1737-1746.
36. Lidow M.S., Goldman-Rakic P.S., Rakic P. Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc. Nat. Acad. Sci. U.S.A. 88:1991;10218-10221.
37. Lidow M.S., Rakic P. Unique profiles of the α1-, α2-, and β-adrenergic receptors in the developing cortical plate and transient embryonic zones of the rhesus monkey. J. Neurosci. 14:1994;4064-4078.
38. 2-adrenergic receptors in fetal rat heart: receptors in search of a function. J. Dev. Physiol. 17:1992;183-187.
39. Lorton D., Bartolome J., Slotkin T.A., Davis J.N. Development of brain beta-adrenergic receptors after neonatal 6-hydroxydopamine treatment. Brain Res. Bull. 21:1988;591-600.
40. 2-adrenergic receptors in the central nervous system. Science. 207:1980;645-647.
41. McMillian M.K., Schanberg S.M., Kuhn C.M. Ontogeny of rat hepatic adrenoceptors. J. Pharmacol. Exp. Ther. 227:1983;181-186.
42. Morris G., Slotkin T.A. Beta-2 adrenergic control of ornithine decarboxylase activity in brain regions of the developing rat. J. Pharmacol. Exp. Ther. 233:1985;141-147.
43. 2-adrenoceptors in rat brain. Brain Res. 190:1980;268-271.
44. Navarro H.A., Kudlacz E.M., Slotkin T.A. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol. Neonate. 60:1991;127-136.
45. Nye H.E., Seidler F.J., Slotkin T.A. Developmental shift from local to central control of norepinephrine release in the cardiac-sympathetic axis: effects of cocaine and related drugs. J. Pharmacol. Exp. Ther. 259:1991;976-981.
46. Pitzer M., Schmidt M.H., Esser G., Laucht M. Child development after maternal tocolysis with β-sympathomimetic drugs. Child Psychiatry Hum. Dev. 31:2001;165-182.
47. 2-Adrenergic receptors stimulate actin organization in developing fetal rat cardiac myocytes. Life Sci. 72:2003;1455-1466.
48. Queisserluft A., Eggers I., Stolz G., Kieningerbaum D., Schlaefer K. Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations. Am. J. Med. Genet. 63:1996;268-276.
49. Renick S., Seidler F.J., McCook E.C., Slotkin T.A. Neuronal control of cardiac and hepatic macromolecule synthesis in the neonatal rat: effects of sympathectomy. Pediatr. Res. 41:1997;359-363.
50. Rodier P.M. Structural-functional relationships in experimentally induced brain damage. Prog. Brain Res. 73:1988;335-348.
51. Seidler F.J., Bell J.M., Slotkin T.A. Undernutrition and overnutrition in the neonatal rat: long-term effects on noradrenergic pathways in brain regions. Pediatr. Res. 27:1990;191-197.
52. Selvage D.J., Rivier C. Importance of the paraventricular nucleus of the hypothalamus as a component of a neural pathway between the brain and the testes that modulates testosterone secretion independently of the pituitary. Endocrinology. 144:2003;594-598.
53. 2-adrenoceptors Br. J. Pharmacol. 128:1999;1215-1222.
54. T.A. Slotkin, Endocrine control of synaptic development in the sympathetic nervous system: the cardiac-sympathetic axis, in: P.M. Gootman (Eds), Developmental Neurobiology of the Autonomic Nervous System, Humana Press, Clifton, NJ, 1986, pp. 97-133.
55. Slotkin T.A., Auman J.T., Seidler F.J. Ontogenesis of β-adrenoceptor signaling: implications for perinatal physiology and for fetal effects of tocolytic drugs. J. Pharmacol. Exp. Ther. 306:2003;1-7.
56. Slotkin T.A., Baker F.E., Dobbins S.S., Eylers J.P., Lappi S.E., Seidler F.J. Prenatal terbutaline exposure in the rat: selective effects on development of noradrenergic projections to cerebellum. Brain Res. Bull. 23:1989;263-265.
57. Slotkin T.A., Kudlacz E.M., Lappi S.E., Tayyeb M.I., Seidler F.J. Fetal terbutaline exposure causes selective postnatal increases in cerebellar α-adrenergic receptor binding. Life Sci. 47:1990;2051-2057.
58. Slotkin T.A., Lau C., Seidler F.J. β-Adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes and coupling to adenylate cyclase via G-proteins. Toxicol. Appl. Pharmacol. 129:1994;223-234.
59. Slotkin T.A., Levant B., Orband-Miller L., Queen K.L., Stasheff S. Do sympathetic neurons coordinate cellular development in the heart and kidney? Effects of neonatal central and peripheral catecholaminergic lesions on cardiac and renal nucleic acids and proteins. J. Pharmacol. Exp. Ther. 244:1988;166-172.
60. Slotkin T.A., Lorber B.A., McCook E.C., Barnes G.A., Seidler F.J. Neural input and the development of adrenergic intracellular signaling: neonatal denervation evokes neither receptor upregulation nor persistent supersensitivity of adenylate cyclase. Dev. Brain Res. 88:1995;17-29.
61. Slotkin T.A., Seidler F.J. Transient postnatal elevation of norepinephrine content and turnover in brain regions of rats exposed to terbutaline prenatally: evidence for autoregulation of noradrenergic development? Res. Commun. Chem. Pathol. Pharmacol. 76:1992;269-278.
62. Slotkin T.A., Tate C.A., Cousins M.M., Seidler F.J. β-Adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Dev. Brain Res. 131:2001;113-125.
63. Slotkin T.A., Zhang J., Dancel R., Garcia S.J., Willis C., Seidler F.J. β-Adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 60:2000;153-166.
64. G.W. Snedecor, W.G. Cochran, Statistical Methods, Iowa State University Press, Ames, Iowa, 1967.
65. 2-adrenoceptors in the rat kidney: correlation with noradrenergic innervation. Brain Res. 400:1987;91-100.
66. 2-adrenoceptors. J. Neurochem. 78:2001;685-693.
67. Tegner K., Nilsson H.T., Persson C.G.A., Persson K., Ryrfeldt Å. Elimination pathways of terbutaline. Eur. J. Respir. Dis. 65(Suppl. 134):1984;93-100.
68. 2A-adrenergic receptors in the visual cortex of neonatal and adult rats. J. Comp. Neurol. 365:1996;79-95.
69. 2a-Adrenergic receptors are expressed by diverse cell types in the fetal primate cerebral wall. J. Comp. Neurol. 378:1997;493-507.
70. 2A adrenoceptors during rat neocortical development. J. Neurobiol. 38:1999;259-269.
71. Yuan S.Z., Runold M., Hagberg H., Bona E., Lagercrantz H. Hypoxic-ischaemic brain damage in immature rats: effects of adrenoceptor modulation. Eur. J. Paediatr. Neurol. 5:2001;29-35.
72. Zeiders J.L., Seidler F.J., Slotkin T.A. Ontogeny of G-protein expression: control by β-adrenoceptors. Dev. Brain Res. 120:2000;125-134.